Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Xeloda approved in New Zealand as treatment for colorectal cancer

June 16, 2000

IDM signs cancer vaccine agreement with Sanofi-Synthelabo

June 16, 2000

Synthesis, activity and use of new inhibitors of protein farnesyltransferase

June 15, 2000

Fungally produced compound active against human tumor cell lines

June 15, 2000

Ligand receives approvable letter from FDA for Targretin Gel

June 15, 2000

Agouron and PPD Discovery create anticancer genomics alliance

June 15, 2000

AVI BioPharma demonstrates promise of new telomerase inhibitor

June 15, 2000

Trial of therapeutic agent for myelodysplastic syndrome indicates even greater potential

June 14, 2000

Preparation and use of new thiazole antitumor agents acting on cdk/cyclin complexes

June 13, 2000

U.S. scientists modify RNase A polypeptides to obtain selective cytotoxicity against KS cells

June 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...